Chris Walsh

Chris Walsh is the General Counsel at Denali Therapeutics with extensive experience in legal roles, particularly in intellectual property. Previously, Chris held various positions at companies such as Genentech and Sterne, Kessler, Goldstein & Fox. Chris has a J.D. from The George Washington University Law School, as well as degrees in Chemistry from Illinois Institute of Technology and Illinois State University. Additionally, Chris has a background in postdoctoral research in Organic Chemistry from Northwestern University.